AriBio

AriBio Co., Ltd. is a clinical-stage biotechnology company headquartered in Seongnam, South Korea, focusing on developing novel therapies for neurodegenerative diseases. Its U.S. office, located in San Diego, manages global clinical operations and regulatory affairs. Its lead product, AR1001, was initially developed by SK Chemicals and has been licensed since 2011 for the development of Alzheimer’s disease treatments.